Gyre Therapeutics, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2011 | 2,999.45x | $1.46 | $4,386.38 |
| Dec 2012 | 4,007.22x | $0.86 | $3,449.25 |
| Jun 2013 | 5,703.17x | $0.57 | $3,268.13 |
| Dec 2014 | 5,587.43x | $0.37 | $2,071.13 |
| Jun 2015 | 96,311.70x | $0.00 | $352.13 |
| Dec 2020 | 99.85x | $0.47 | $47.33 |
| Dec 2021 | 58.43x | $0.12 | $6.83 |
| Jun 2022 | 75.11x | $0.11 | $7.95 |
| Dec 2023 | 14.91x | $1.72 | $25.69 |
| Dec 2024 | 11.70x | $1.03 | $12.10 |
| Dec 2025 | 6.21x | $1.13 | $7.02 |